GCL
HZNP

Glazer Capital LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Glazer Capital LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,002,282
Closed -$116M – 209
2023
Q3 		$116M Buy
+1,002,282
New +$116M 7.55% 2
2023
Q1 		– Sell
-360,496
Closed -$41M – 581
2022
Q4 		$41M Buy
+360,496
New +$41M 1.06% 11